EW
DNA icon

Evoke Wealth’s Ginkgo Bioworks DNA Stock Holding History

Evoke Wealth’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$12K – 574
2022
Q3 		$12K Buy
+100
New +$11.9K ﹤0.01% 719
2022
Q2 		– Sell
-50
Closed -$8K – 1192
2022
Q1 		$8K Hold
50
– – ﹤0.01% 804
2021
Q4 		$17K Hold
50
– – ﹤0.01% 703
2021
Q3 		$23K Buy
+50
New +$24.3K ﹤0.01% 614

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Evoke Wealth's DNA Position: Q4 2022 in Review

Evoke Wealth sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 100 shares — an estimated $12K sold.

Evoke Wealth first reported a position in DNA in Q3 2021 and held it in 4 quarters. The position peaked at $23K in Q3 2021. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

  • Evoke Wealth reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 100 Ginkgo Bioworks shares in Q4 2022, an estimated $12K.
  • Evoke Wealth first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 4 quarters.
  • Evoke Wealth's Ginkgo Bioworks position peaked at $23K in Q3 2021.
  • 320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.